Search
for
Sort by
Research 481–510 of 1000+
- II Consensus of the Brazilian Society of Dermatology for the treatment of alopecia areata
- Two phase III trials of baricitinib for alopecia areata: a critically appraised research paper
- Acne exacerbation after tofacitinib treatment for alopecia areata
- Erosive pustular dermatosis of the scalp induced by gefitinib: case and review of the literature
- Childhood Alopecia Areata: An Overview of Treatment and Recent Patents
- What’s New in Hair Loss
- Taiwanese Dermatological Association consensus on the diagnosis and management of alopecia areata
- Ruxolitinib 1.5% Topical Cream for the Treatment of Pediatric Alopecia Areata
- Biologics in the management of childhood atopic dermatitis
- Tofacitinib as a pragmatic treatment choice for alopecia areata: A retrospective review
- The Dark Side of Gefitinib: Reflectance Confocal Microscopy Applied to Hair Hyperpigmentation
- The Role of Tofacitinib in the Management of Alopecia Totalis
- Successful Treatment of Severe Alopecia Areata With Oral or Topical Tofacitinib.
- Unusual progression of renal cell carcinoma with carcinomatosis peritoneii and Krukenberg tumour and alopecia with sunitinib therapy in young female
- Real-world assessment of ritlecitinib in patients with severe alopecia areata: a 24-week multicentre retrospective study
- Relapse of Alopecia Areata Responders After Tofacitinib Withdrawal: A Retrospective Study of 59 Patients
- Treatment of discoid lupus erythematosus scarring alopecia with deucravacitinib: A case report
- FDA approval of Deuruxolitinib: A New Treatment Option for Severe Alopecia Areata
- The Importance of Readability: A Guide to Understanding Alopecia Areata through Multilingual Online Resources
- SDRIFE Induced by Tofacitinib
- Real-world experience quantifying access to JAK inhibitor care for alopecia areata patients: a patient-centered survey study
- Recent advances in exosomal non‐coding RNA‐based therapeutic approaches for photoaging
- Upadacitinib for management of recalcitrant alopecia areata: A retrospective case series
- Alopecias in humans: biology, pathomechanisms and emerging therapies
- LB785 Efficacy and safety of baricitinib in adults with Alopecia Areata: Phase 3 results from a randomized controlled trial (BRAVE-AA1)
- PNKP is required for maintaining the integrity of progenitor cell populations in adult mice
- Recent Insight on the Management of Lupus Erythematosus Alopecia
- 691 Topical curcumin promotes induction of the murine hair cycle
- A serious side effect of a potentially widely used cosmetic product
- Autoimmune Hair Loss Induced by Alloantigen in C57BL/6 Mice.